Rebecka Grund

FrostPharma AB is a Swedish specialty pharmaceutical company that focuses on commercializing value-adding medicines. The company is based in Danderyd, Sweden. The company has an established specialty pharma platform across the Nordics and plans to expand to additional EU countries. FrostPharma's portfolio of products is primarily oriented toward hospital use and initiation. In addition, the company has developed a separate division that offers sustainable solutions to petroleum-based plastics across the healthcare sector. The company was founded in 2017 by Clas Lindbergson and Göran Heinz. The CEO is Fredrik Andersch.

FrostPharma AB is a Swedish specialty pharmaceutical company that focuses on commercializing value-adding medicines. The company is based in Danderyd, Sweden. The company has an established specialty pharma platform across the Nordics and plans to expand to additional EU countries. FrostPharma's portfolio of products is primarily oriented toward hospital use and initiation. In addition, the company has developed a separate division that offers sustainable solutions to petroleum-based plastics across the healthcare sector. The company was founded in 2017 by Clas Lindbergson and Göran Heinz. The CEO is Fredrik Andersch.

FrostPharma AB is a Swedish specialty pharmaceutical company that focuses on commercializing value-adding medicines. The company is based in Danderyd, Sweden. The company has an established specialty pharma platform across the Nordics and plans to expand to additional EU countries. FrostPharma's portfolio of products is primarily oriented toward hospital use and initiation. In addition, the company has developed a separate division that offers sustainable solutions to petroleum-based plastics across the healthcare sector. The company was founded in 2017 by Clas Lindbergson and Göran Heinz. The CEO is Fredrik Andersch.

FrostPharma AB is a Swedish specialty pharmaceutical company that focuses on commercializing value-adding medicines. The company is based in Danderyd, Sweden. The company has an established specialty pharma platform across the Nordics and plans to expand to additional EU countries. FrostPharma's portfolio of products is primarily oriented toward hospital use and initiation. In addition, the company has developed a separate division that offers sustainable solutions to petroleum-based plastics across the healthcare sector. The company was founded in 2017 by Clas Lindbergson and Göran Heinz. The CEO is Fredrik Andersch.

FrostPharma AB is a Swedish specialty pharmaceutical company that focuses on commercializing value-adding medicines. The company is based in Danderyd, Sweden. The company has an established specialty pharma platform across the Nordics and plans to expand to additional EU countries. FrostPharma's portfolio of products is primarily oriented toward hospital use and initiation. In addition, the company has developed a separate division that offers sustainable solutions to petroleum-based plastics across the healthcare sector. The company was founded in 2017 by Clas Lindbergson and Göran Heinz. The CEO is Fredrik Andersch.